![James J. Antonopoulos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James J. Antonopoulos
Geen lopende functies
Profiel
James J.
Antonopoulos formerly worked at MabVax Therapeutics Holdings, Inc., as Director and Canaccord Genuity Group, Inc., as Principal.
Mr. Antonopoulos received his graduate degree in 2007 from Villanova University School of Law.
Eerdere bekende functies van James J. Antonopoulos
Bedrijven | Functie | Einde |
---|---|---|
CANACCORD GENUITY GROUP INC. | Corporate Officer/Principal | - |
MABVAX THERAPEUTICS HOLDINGS, INC. | Directeur/Bestuurslid | - |
Opleiding van James J. Antonopoulos
Villanova University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CANACCORD GENUITY GROUP INC. | Finance |
Bedrijven in privébezit | 1 |
---|---|
MabVax Therapeutics Holdings, Inc.
![]() MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |